Showing results (271-280 of 322) with videos related to
Sort By:
Pageof 33
Bone Marrow Transplantation|August 31, 2004
Transmission of donor illness by stem cell transplantation: should screening be different in older donors?D Niederwieser, C Gentilini, U Hegenbart, et al.Bone Marrow Transplantation|April 8, 2009
Outcome after allogeneic transplantation for adult acute myeloid leukemia patients exhibiting isolated or associated trisomy 8 chromosomal abnormality: a survey on behalf of the ALWP of the EBMTP Chevallier, M Labopin, A Nagler, et al.Acta Haematologica|March 8, 2000
Current results of bone marrow transplantation in patients with acquired severe aplastic anemia. Report of the European Group for Blood and Marrow transplantation. On behalf of the Working Party on Severe Aplastic Anemia of the European Group for Blood and Marrow TransplantationA Bacigalupo, R Oneto, B Bruno, et al.Lancet (London, England)|August 11, 2001
Pregnancy outcomes after peripheral blood or bone marrow transplantation: a retrospective surveyN Salooja, R M Szydlo, G Socie, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 1998
High-dose induction chemoradiotherapy followed by autologous bone marrow transplantation as consolidation therapy in rhabdomyosarcoma, extraosseous Ewing's sarcoma, and undifferentiated sarcomaF Boulad, N A Kernan, M P LaQuaglia, et al.Bone Marrow Transplantation|December 17, 2008
A prospective randomized controlled trial comparing PCR-based and empirical treatment with liposomal amphotericin B in patients after allo-SCTH Hebart, L Klingspor, T Klingebiel, et al.Seminars in Hematology|February 17, 2000
Treatment of acquired severe aplastic anemia: bone marrow transplantation compared with immunosuppressive therapy--The European Group for Blood and Marrow Transplantation experienceA Bacigalupo, R Brand, R Oneto, et al.Annals of Internal Medicine|November 30, 1999
Malignant neoplasms in long-term survivors of bone marrow transplantation. Late Effects Working Party of the European Cooperative Group for Blood and Marrow Transplantation and the European Late Effect Project GroupH J Kolb, G Socié, T Duell, et al.Transplantation|September 30, 1998
Low incidence of acute graft-versus-host disease, using unrelated HLA-A-, HLA-B-, and HLA-DR-compatible donors and conditioning, including anti-T-cell antibodiesO Ringdén, M Remberger, S Carlens, et al.Blood|September 1, 1995
Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patientsH J Kolb, A Schattenberg, J M Goldman, et al.Pageof 33